NanoGVA Symposium

The 2nd NanoGVA Symposium “Creating the Invisible: the development of nanomedicines” will be hosted by the University of Geneva on October 5-6, 2023. The symposium will deal with relevant topics like new characterization methods of advanced materials, manufacturing processes and the regulatory background of nanomedicines.

Related articles

Characterizing Nanopartic... Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link
Microplastics and Nanopla... Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
The MACRAMÉ Project, a 36-months research and innovation action, funded by the European Commission’s Horizon Europe Framework Programme, commenced its ambitious, collaborative workprogramme on the characterisation and
Medical Device Regulation... Join us on December 14, 2020 for contactpointnano.ch‘s second webinar and learn about how to navigate new regulations for medical devices and new requirements regarding nanomaterials. Time: 13.00
Questions about nanomater... New initiative to pool know-how on synthetic nanomaterials in Switzerland Hönggerberg, June 7, 2018 – At the Swiss Nano Convention 2018, taking place at ETH Zurich this
Subscribe to our newslett... Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Country-scale calculation... Plastic particles less than five millimeters in size, also known as microplastics, often settle far away from their point of origin. Empa researchers have now developed a
Guidelines: Safe-by-desig... A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises
Safe-by-design and EU fun... Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
Crucial results for coron... Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are